Skip to Main Content

Paper Details

Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.
NPJ Breast Cancer
7
2021
EpiView, HER2, HER2-negative and HER2-positve tumors, breast cancer, breast tumor, cancer, cancer cell lines, cell lines, fine-needle aspirates, human, human epidermal growth factor receptor-2, immunodiagnostic chip, tumor
Author NameAffiliation
Gray R AndersonDuke University School of Medicine
Terry HyslopDuke University Medical Center
Kris C WoodDuke University School of Medicine
Ashutosh ChilkotiDuke University
  • 1 - 4

Datasets

Release 1.2